Table 5 The association between two SNPs genotypes and clinical characteristics of patients with BC in dominant model
Characteristics | rs17083838 Genotype | P valuea | rs7992670 Genotype | P valuea | ||
|---|---|---|---|---|---|---|
GG | AG/AA | GG | AG/AA | |||
Age | Â | Â | Â | Â | Â | Â |
 ≤ 63 years old | 101(84.2%) | 19(15.8%) | 0.81 | 46(38.3%) | 74(61.7%) | 0.18 |
 >63 years old | 125(82.8%) | 26(17.2%) | 48(31.8%) | 103(68.2%) | ||
Sex | Â | Â | Â | Â | Â | Â |
 Male | 179(82.9%) | 37(17.1%) | 0.23 | 78(36.1%) | 138(63.9%) | 0.034 |
 Female | 47(85.5%) | 8(14.6%) | 16(29.1%) | 39(70.9%) | ||
Smoke | Â | Â | Â | Â | Â | Â |
 Smoker | 120(85.1%) | 21(14.9%) | 0.26 | 42(29.8%) | 99(70.2%) | 0.0098 |
 Nonsmoker | 106(81.5%) | 24(18.5%) | 52(40%) | 78(60%) | ||
Tumor stage | Â | Â | Â | Â | Â | Â |
 MIBC | 110(84%) | 21(16%) | 0.69 | 44(33.6%) | 87(66.4%) | 0.62 |
 NMIBC | 116(82.9%) | 24(17.1%) | 50(35.7%) | 90(64.3%) | ||
Tumor grade | Â | Â | Â | Â | Â | Â |
 High grade | 136(84%) | 26(16.1%) | 0.68 | 55(34%) | 107(66%) | 0.99 |
 Low grade | 90(82.6%) | 19(17.4%) | 39(35.8%) | 70(64.2%) | ||
Recurrence | Â | Â | Â | Â | Â | Â |
 Recurrent | 69(87.3%) | 10(12.7%) | 0.12 | 28(35.4%) | 51(64.6%) | 0.83 |
 Nonrecurrent | 157(81.8%) | 35(18.2%) | 66(34.4%) | 126(65.6%) | ||
Metastasis | Â | Â | Â | Â | Â | Â |
 Metastatic | 38(79.2%) | 10(20.8%) | 0.19 | 19(39.6%) | 29(60.4%) | 0.38 |
 Nonmetastatic | 188(84.3%) | 35(15.7%) | 75(33.6%) | 148(66.4%) | ||